You have 9 free searches left this month | for more free features.

Hyperlipidemias

Showing 26 - 50 of 676

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HIV/AIDS, Hypertension, Hyperlipidemias Trial in Durham, Cleveland (Multi-component intervention, General prevention education)

Completed
  • HIV/AIDS
  • +2 more
  • Multi-component intervention
  • General prevention education
  • Durham, North Carolina
  • +2 more
Jan 23, 2023

Dyslipidemias, Hyperlipidemias, Liver Transplant Disorder Trial in Moscow (Pitavastatin, PCSK9 inhibitor)

Recruiting
  • Dyslipidemias
  • +5 more
  • Moscow, Russian Federation
    National Medical Research Centre for Therapy and Preventive Medi
Sep 8, 2022

Cardiometabolic Disease, Hyperlipidemia Trial in Beijing (Telehealth integrated care, Conventional health care)

Recruiting
  • Cardiometabolic Disease
  • Hyperlipidemia
  • Telehealth integrated care
  • Conventional health care
  • Beijing, Beijing, China
    Peking University Third Hospital
Sep 1, 2023

Cardiovascular Diseases, Myocardial Infarction, Atrial Fibrillation Trial in New York (Care coordination delivered based on

Not yet recruiting
  • Cardiovascular Diseases
  • +9 more
  • Care coordination delivered based on perceived need
  • Care coordination delivered based on usual care (e.g. discharge from hospital)
  • New York, New York
    New York Presbyterian Hospital - Weill Cornell Medicine
Apr 7, 2023

Obesity, Obesity, Morbid, Obesity, Primary Trial in Boston (Blood Collection, Urine Collection, Tissue Sample Collection)

Not yet recruiting
  • Obesity
  • +16 more
  • Blood Collection
  • +2 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
May 23, 2023

Type 1 Hyperlipoprotenemia Trial (Orlistat, Placebo)

Not yet recruiting
  • Type 1 Hyperlipoprotenemia
  • (no location specified)
Apr 14, 2023

Hyperlipidemia, Hyperglycemia, Type 2 Diabetes Trial in Taipei (Adlay with white rice, white rice)

Recruiting
  • Hyperlipidemia
  • +2 more
  • Adlay with white rice
  • white rice
  • Taipei, Taiwan
    National Taiwan University Hospital
Aug 17, 2023

Hyperlipidemias Trial in Dhaka (Zinc sulfate, Placebo)

Recruiting
  • Hyperlipidemias
  • Zinc sulfate
  • Placebo
  • Dhaka, Bangladesh
    Bangabandhu Sheikh Mujib Medical University
May 24, 2022

Hyperlipidemias Trial in Boston (Evolocumab, Statins (Cardiovascular Agents))

Recruiting
  • Hyperlipidemias
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 18, 2022

Hyperlipidemias Trial in Portland (Fruit and vegetable deliveries)

Completed
  • Hyperlipidemias
  • Fruit and vegetable deliveries
  • Portland, Oregon
    Oregon Health & Science University
Apr 18, 2022

Obesity, Hyperlipidemias Trial in Singapore (Simvastatin)

Recruiting
  • Obesity
  • Hyperlipidemias
  • Singapore, Singapore
    National University Hospital
Apr 7, 2022

Hyperlipidemia Trial in Beijing (JS401, Placebo)

Recruiting
  • Hyperlipidemia
  • Beijing, Beijing, China
    Peking University Third Hospital
Sep 15, 2023

Lipoprotein Metabolism in Normal Volunteers and High Levels of

Completed
  • Hypolipoproteinemia
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Inflammation, Hypertriglyceridemia, Metabolic Disease Trial in Bozeman (Lentil, Control)

    Recruiting
    • Inflammation
    • +5 more
    • Lentil
    • Control
    • Bozeman, Montana
      Nutrition Research Laboratory
    Apr 6, 2022

    Hypertriglyceridemia Trial in Hellerup (DHA-NAT, Placebo)

    Recruiting
    • Hypertriglyceridemia
    • DHA-NAT
    • Placebo
    • Hellerup, Denmark
      Center for Clinical Metabolic Research, Herlev-Gentofte Hospital
    Jul 11, 2023

    Diabetes, Lipodystrophy, Hyperlipidemia Trial run by the NIDDK (Metreleptin)

    Active, not recruiting
    • Diabetes
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 21, 2023

    Hyperlipidemias Trial in Toronto (Teduglutide, Placebo)

    Completed
    • Hyperlipidemias
    • Toronto, Ontario, Canada
    • +1 more
    May 18, 2022

    Hyperlipidemias, Hypercholesterolemia Trial in Cheras (Placebo, 250 mg OPP)

    Completed
    • Hyperlipidemias
    • Hypercholesterolemia
    • Placebo
    • 250 mg OPP
    • Cheras, WP Kuala Lumpur, Malaysia
      National University of Malaysia
    Apr 5, 2022

    Hypertension and Hyperlipidemia Trial in Philadelphia (HTN and Medication Adherence)

    Recruiting
    • Hypertension and Hyperlipidemia
    • HTN and Medication Adherence
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Sep 27, 2022

    Hyperlipoproteinemia (a) Trial (Pelacarsen)

    Not yet recruiting
    • Hyperlipoproteinemia (a)
    • (no location specified)
    Jun 2, 2023

    Program With Lipid Screening asMeans to Identify Familial

    Enrolling by invitation
    • Familial Hyperlipidemia
      • Loveland, Colorado
        Medical Center of the Rockies
      Mar 2, 2023

      Lipodystrophy, Diabetes, Hyperlipidemia Trial run by the NIDDK (Metreleptin)

      Recruiting
      • Lipodystrophy
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Acute Coronary Syndrome, Hyperlipidemias, Percutaneous Coronary Intervention Trial in Nanjing (Placebo plus high-intensity

      Not yet recruiting
      • Acute Coronary Syndrome
      • +3 more
      • Placebo plus high-intensity statin
      • PCSK 9 Inhibitor plus high-intensity statin
      • Nanjing, Jiangsu, China
        Nanjing First Hospital
      Aug 1, 2022

      NASH - Nonalcoholic Steatohepatitis, Diabetes, Type 2, Hyperlipidemias Trial in Frankfurt, Mainz (Nutritional Intervention)

      Active, not recruiting
      • NASH - Nonalcoholic Steatohepatitis
      • +2 more
      • Nutritional Intervention
      • Frankfurt, Germany
      • +1 more
      Mar 28, 2022

      Improving Systolic BP and LDL-C Compared to Conventional

      Not yet recruiting
      • Hyperlipidemias
      • Hypertension
      • Rosuvastatin, Olmesartan Medoxomil
      • (no location specified)
      Jun 6, 2022